Drug safety updates, recalls and regulatory warnings from MHRA, organised for rapid clinical review and specialty follow-up.
Parenteral nutrition must be administered through appropriate filters across all care settings to prevent particulate matter embolism, which can be fatal Non-filtered PN administration represents a significant patient safety risk and has been linked…
02 Sep 2026 · Read clinical summaryHealthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of SABA with or without anti-inflammatory maintenance therapy in…
Fezolinetant treatment is associated with a risk of drug induced liver injury. New recommendations have been introduced to minimise this risk. Liver function should be monitored before and…
Prolonged-release opioids: Removal of indication for relief of post-operative pa...
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. This update is best treated as a linked clinical news item for…
Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chrono...
Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor agonists who undergo surgery or procedures with general…
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. This update is best treated as a linked clinical news item for…
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. This update is best treated as a linked clinical news item for…
The ninth annual #MedSafetyWeek social media campaign is taking place 4 to 10 November 2024. This update is best treated as a linked clinical news item for awareness…
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. This update is best treated as a linked clinical news item for…
Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). This update is most useful for treatment…
We ask healthcare professionals to support new guidance for users of diabetes management equipment, their families, care givers and representatives. This update is most useful for treatment counselling,…